Zhang YB - Search Results

1

[Mechanism of regulation of leptin expression in human lung adenocarcinoma cells by hypoxia inducible factor-1alpha: a preliminary study].

Zhang YB, Fang M, He FL, Hua TF, Hu BD, Zhao H, Liu RY. Zhang YB, et al. Zhonghua Yi Xue Za Zhi. 2008 Nov 4;88(40):2848-53. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19080496 Chinese.

2

Increased expression of Toll-like receptors 4 and 9 in human lung cancer.

Zhang YB, He FL, Fang M, Hua TF, Hu BD, Zhang ZH, Cao Q, Liu RY. Zhang YB, et al. Among authors: zhang zh. Mol Biol Rep. 2009 Jul;36(6):1475-81. doi: 10.1007/s11033-008-9338-9. Epub 2008 Sep 2. Mol Biol Rep. 2009. PMID: 18763053

3

CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.

Xu P, Xu XL, Huang Q, Zhang ZH, Zhang YB. Xu P, et al. Among authors: zhang yb, zhang zh. Med Oncol. 2012 Sep;29(3):1643-7. doi: 10.1007/s12032-011-0053-3. Epub 2011 Aug 28. Med Oncol. 2012. PMID: 21874565

4

Synergistic Effect of Notch-3-Specific Inhibition and Paclitaxel in Non-Small Cell Lung Cancer (NSCLC) Cells Via Activation of The Intrinsic Apoptosis Pathway.

He F, Du T, Jiang Q, Zhang Y. He F, et al. Med Sci Monit. 2017 Aug 3;23:3760-3769. doi: 10.12659/msm.902641. Med Sci Monit. 2017. PMID: 28769027 Free PMC article.

5

Specific inhibitor of Notch‑3 enhances the sensitivity of NSCLC cells to gemcitabine.

Hu BD, Guo J, Ye YZ, Du T, Cheng CS, Jiang Q, Liu RN, Zhang YB. Hu BD, et al. Among authors: zhang yb. Oncol Rep. 2018 Jul;40(1):155-164. doi: 10.3892/or.2018.6448. Epub 2018 May 16. Oncol Rep. 2018. PMID: 29781034 Free PMC article.

6

Successful steroid treatment for acute fibrinous and organizing pneumonia: A case report.

Ning YJ, Ding PS, Ke ZY, Zhang YB, Liu RY. Ning YJ, et al. Among authors: zhang yb. World J Clin Cases. 2018 Dec 6;6(15):1053-1058. doi: 10.12998/wjcc.v6.i15.1053. World J Clin Cases. 2018. PMID: 30568963 Free PMC article.

7

Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer.

Ye YZ, Zhang ZH, Fan XY, Xu XL, Chen ML, Chang BW, Zhang YB. Ye YZ, et al. Among authors: zhang yb, zhang zh. Med Oncol. 2013;30(2):595. doi: 10.1007/s12032-013-0595-7. Epub 2013 May 7. Med Oncol. 2013. PMID: 23645556

8

Excellent response of lung adenocarcinoma harboring a rare SLC8A1 downstream intergenic region ALK fusion to ceritinib treatment: A case report.

Fang L, Ding G, Wang M, Ye Y, Yan X, Ding P, Wang J, Zhang Y. Fang L, et al. Medicine (Baltimore). 2022 Aug 26;101(34):e30255. doi: 10.1097/MD.0000000000030255. Medicine (Baltimore). 2022. PMID: 36042596 Free PMC article.

9

Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study.

Xu L, Xu F, Kong H, Zhao M, Ye Y, Zhang Y. Xu L, et al. BMC Cancer. 2020 Nov 26;20(1):1152. doi: 10.1186/s12885-020-07650-2. BMC Cancer. 2020. PMID: 33243184 Free PMC article.

10

Correlation analysis between serum neuron-specific enolase and the detection of gene mutations in lung adenocarcinoma.

Xu FZ, Zhang YB. Xu FZ, et al. Among authors: zhang yb. J Thorac Dis. 2021 Feb;13(2):552-561. doi: 10.21037/jtd-20-1633. J Thorac Dis. 2021. PMID: 33717528 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,074 results

Search Page

Filters